(-0.13%) 5 461.97 points
(-0.35%) 38 977 points
(0.25%) 17 762 points
(0.45%) $81.19
(-3.48%) $2.66
(-1.01%) $2 307.30
(-0.48%) $28.73
(1.53%) $1 001.50
(0.27%) $0.936
(0.82%) $10.69
(0.36%) $0.791
(-0.16%) $87.35
Live Chart Being Loaded With Signals
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease risk assessment test...
Stats | |
---|---|
本日の出来高 | 4 439 |
平均出来高 | 0 |
時価総額 | 12.31M |
EPS | $-0.200 ( Q1 | 2024-05-15 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
0 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0 (0.00%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-12-18 | Burton Paul Frederick | Buy | 0 | |
2023-12-31 | Levy Oded | Buy | 5 020 | Common Stock |
2023-12-31 | Levy Oded | Sell | 0 | Restricted Stock Units |
2023-12-31 | Sim Brandon | Buy | 5 020 | Common Stock |
2023-12-31 | Sim Brandon | Sell | 0 | Restricted Stock Units |
INSIDER POWER |
---|
100.00 |
Last 61 transactions |
Buy: 2 578 621 | Sell: 0 |
Cardio Diagnostics 財務諸表
Annual | 2023 |
収益: | $17 065.00 |
総利益: | $-94 555.00 (-554.09 %) |
EPS: | $-0.660 |
FY | 2023 |
収益: | $17 065.00 |
総利益: | $-94 555.00 (-554.09 %) |
EPS: | $-0.660 |
FY | 2022 |
収益: | $950.00 |
総利益: | $-15 050.00 (-1 584.21 %) |
EPS: | $-1.510 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Cardio Diagnostics
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease risk assessment test. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is based in Chicago, Illinois.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。